PubRank

Marek Hartleb

Author PubWeight™ 17.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol 2010 1.69
2 Kidneys in chronic liver diseases. World J Gastroenterol 2012 1.10
3 Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension. World J Gastroenterol 2011 1.00
4 Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature. Hepat Mon 2011 0.97
5 Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery. Pol J Pathol 2010 0.87
6 Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol 2010 0.85
7 Composite neuroendocrine and adenomatous carcinoma of the papilla of Vater. World J Gastroenterol 2009 0.85
8 Severe dilated cardiomyopathy as a consequence of Ecstasy intake. Cardiovasc Pathol 2007 0.84
9 Laboratory-based scoring system for prediction of hepatic inflammatory activity in patients with autoimmune hepatitis. Liver Int 2013 0.81
10 Haemobilia causing acute pancreatitis after percutaneous liver biopsy. J Hepatol 2004 0.79
11 Hepatic angiogenesis and fibrosis are common features in morbidly obese patients. Hepatol Int 2011 0.79
12 [Significance of serum concentrations of pro- and anti-inflammatory cytokines in identification of patients with Crohn's disease]. Pol Merkur Lekarski 2010 0.78
13 Comment on "Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta". J Immunol 2009 0.77
14 Serum vaspin may be a good indicator of fibrosis in chronic hepatitis C and is not altered by antiviral therapy. Pol J Pathol 2012 0.77
15 Omentin serum concentration and hepatic expression in chronic hepatitis C patients - together or apart? Pol J Pathol 2015 0.77
16 In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol 2013 0.77
17 Treatment of pruritus with Prometheus dialysis and absorption system in a patient with benign recurrent intrahepatic cholestasis. Hepatol Res 2013 0.76
18 Critical flicker frequency fails to disclose brain dysfunction in patients with primary biliary cirrhosis. Dig Liver Dis 2010 0.76
19 Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective observational cohort study in Poland, Egypt, Mexico and China. Clin Drug Investig 2014 0.76
20 Age and immunoglobulin G4-associated autoimmune hepatitis. Liver Int 2009 0.75
21 A composite model including visfatin, tissue polypeptide-specific antigen, hyaluronic acid, and hematological variables for the diagnosis of moderate-to-severe fibrosis in nonalcoholic fatty liver disease: a preliminary study. Pol Arch Med Wewn 2014 0.75
22 [Alcoholic liver disease]. Wiad Lek 2003 0.75
23 Cytophagic hemorrhagic panniculitis and severe steatohepatitis: challenging combination. J Gastroenterol Hepatol 2005 0.75
24 [Evaluation of probability of bile duct stone presence by using of non-invasive procedures]. Pol Arch Med Wewn 2003 0.75
25 [85-years-old patient with paraneoplastic polyneuropathy]. Wiad Lek 2007 0.75
26 An unusual cause of hepatic encephalopathy. Pol Arch Med Wewn 2015 0.75
27 Left-hemihepatectomy as a method of treatment of locally limited Caroli disease. Pol Przegl Chir 2013 0.75
28 [Inflammatory bowel diseases in pregnancy]. Ginekol Pol 2009 0.75
29 Vaspin mRNA levels in the liver of morbidly obese women with nonalcoholic fatty liver disease. Pol J Pathol 2017 0.75
30 Comparison of patency and cost-effectiveness of self-expandable metal and plastic stents used for malignant biliary strictures: a Polish single-center study. Eur J Gastroenterol Hepatol 2016 0.75
31 Autoimmune LKM1 hepatitis presenting in the form of recurrent acute episodes. Am J Gastroenterol 2002 0.75
32 [Assessment of prevalence of intrapulmonary arterio-venous shunt in cirrhotic patients qualified to liver transplantation]. Wiad Lek 2009 0.75
33 Moyamoya-like vascular pattern of the hepatic portal in primary sclerosing cholangitis associated with portal vein occlusion. Ultraschall Med 2007 0.75
34 Hepatic arterial dot signs in isolated small duct primary sclerosing cholangitis. J Gastroenterol Hepatol 2004 0.75
35 [Autoimmune hepatitis in the sight of contemporary immunology]. Pol Arch Med Wewn 2002 0.75
36 Hepatic chemerin mRNA in morbidly obese patients with nonalcoholic fatty liver disease. Pol J Pathol 2017 0.75
37 [Serum level of TNF-alpha receptor type II better correlates with severity of Crohn's disease than other cytokines and conventional clinical activity indicators]. Pol Merkur Lekarski 2010 0.75
38 A rare cause of chylous ascites. Liver Int 2011 0.75
39 [Endoscopic assessment of large bowel and safety of bowel preparation and sedoanalgesia in patients with advanced liver cirrhosis]. Przegl Lek 2011 0.75
40 Pernicious anemia during peginterferon-alpha2b plus ribavirin therapy for chronic hepatitis C. Eur J Gastroenterol Hepatol 2009 0.75